✦ LIBER ✦

Randomised trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: preliminary results of the SITAM-01

✍ Scribed by M. Sacco; M. Valentini; M. Belfiglio; A. Nicolucci; F. Pellegrini

Book ID: 117658406
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 141 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81040-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twelve-year mortality results of a rando

Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01)

✍ Carol Alliot 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 1 views

Twelve-year mortality results of a rando

Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01)

✍ Maurizio Belfiglio; Miriam Valentini; Fabio Pellegrini; Giorgia De Berardis; Mon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND This study evaluated the impact on overall survival (OS) of 2 versus 5 years adjuvant tamoxifen in early breast carcinoma patients after 12 years of follow‐up. ## METHODS Women with breast carcinoma T1–3, N0–3, M0, aged 50–70 years, were eligible for this multicenter ra

Randomized trial of two versus five year

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: Swedish Breast Cancer Cooperative Group J Natl Cancer Inst 1996:88:1543-49

📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 224 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 150 KB

A Randomized Trial of Letrozole in Postm

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

✍ Goss, Paul E.; Ingle, James N.; Martino, Silvana; Robert, Nicholas J.; Muss, Hym 📂 Article 📅 2003 🏛 Massachusetts Medical Society 🌐 English ⚖ 219 KB

P101 Randomized trial of two versus four

P101 Randomized trial of two versus four years of adjuvant tamoxifen (AT) for postmenopausal women with node positive breast cancer

✍ M. Gallén; C. Alonso; B. Ojeda; P. Viladiu; M. Beltrán; J. Borras; A. Pelegri; I 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB